Endo Pharmaceuticals Holdings Inc. is a specialty pharmaceutical solutions company, focused on high-value branded products and specialty generics. The company delivers an innovative suite of complementary diagnostics, drugs, devices and clinical data to meet the needs of patients in areas such as pain, urology, oncology and endocrinology.
Endo Pharmaceuticals is currently trading 1.41% versus its previous trading session close, and it has calculated support and resistance at $33.46 and $39.24 respectively. Clearly with this action this range has been penetrated, and traders will be reviewing price action to establish a new tradable range
The overall market index S&P 500 is trading lower by -0.27% from its previous trading close, which means that Endo Pharmaceuticals stock is outperforming the overall market.
No comments:
Post a Comment